267 related articles for article (PubMed ID: 23380959)
1. MicroRNAs in endometrial cancer.
Banno K; Yanokura M; Kisu I; Yamagami W; Susumu N; Aoki D
Int J Clin Oncol; 2013 Apr; 18(2):186-92. PubMed ID: 23380959
[TBL] [Abstract][Full Text] [Related]
2. [The role of miRNA in endometrial cancer in the context of miRNA 205].
Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
Boren T; Xiong Y; Hakam A; Wenham R; Apte S; Wei Z; Kamath S; Chen DT; Dressman H; Lancaster JM
Gynecol Oncol; 2008 Aug; 110(2):206-15. PubMed ID: 18499237
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.
Kontomanolis EN; Koukourakis MI
Microrna; 2015; 4(1):18-25. PubMed ID: 26088599
[TBL] [Abstract][Full Text] [Related]
5. Small non-coding RNA deregulation in endometrial carcinogenesis.
Ravo M; Cordella A; Rinaldi A; Bruno G; Alexandrova E; Saggese P; Nassa G; Giurato G; Tarallo R; Marchese G; Rizzo F; Stellato C; Biancardi R; Troisi J; Di Spiezio Sardo A; Zullo F; Weisz A; Guida M
Oncotarget; 2015 Mar; 6(7):4677-91. PubMed ID: 25686835
[TBL] [Abstract][Full Text] [Related]
6. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
7. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
8. The role of miRNAs in endometrial cancer.
Vasilatou D; Sioulas VD; Pappa V; Papageorgiou SG; Vlahos NF
Epigenomics; 2015; 7(6):951-9. PubMed ID: 26443384
[TBL] [Abstract][Full Text] [Related]
9. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
11. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
12. Regulatory network of microRNAs, target genes, transcription factors and host genes in endometrial cancer.
Xue LC; Xu ZW; Wang KH; Wang N; Zhang XX; Wang S
Asian Pac J Cancer Prev; 2015; 16(2):475-83. PubMed ID: 25684474
[TBL] [Abstract][Full Text] [Related]
13. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
14. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Ouyang D; Li R; Li Y; Zhu X
Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
[TBL] [Abstract][Full Text] [Related]
15. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
17. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
18. Analysis of microRNA regulating cell cycle-related tumor suppressor genes in endometrial cancer patients.
Witek Ł; Janikowski T; Gabriel I; Bodzek P; Olejek A
Hum Cell; 2021 Mar; 34(2):564-569. PubMed ID: 33123872
[TBL] [Abstract][Full Text] [Related]
19. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.
Banno K; Nogami Y; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Susumu N; Aoki D
Int J Mol Sci; 2013 Jun; 14(6):12123-37. PubMed ID: 23743825
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS
Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
